about
Biology and clinical relevance of granulysinGranulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescenceVisiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins.Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes.Cell death mechanisms at the maternal-fetal interface: insights into the role of granulysin.15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity.In vivo potential of recombinant granulysin against human tumors.Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humansNovel therapeutic vaccines [(HSP65 + IL-12)DNA-, granulysin- and Ksp37-vaccine] against tuberculosis and synergistic effects in the combination with chemotherapy.Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.The Growth Inhibitory Potential and Antimetastatic Effect of Camel Urine on Breast Cancer Cells In Vitro and In Vivo.Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.Granulysin expressed in a humanized mouse model induces apoptotic cell death and suppresses tumorigenicity.Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.The Role of Granulysin in Cancer ImmunologyHuman yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile
P2860
Q24648274-02C23D92-072C-42AC-A697-102ED5CD845DQ28478603-9978B18D-02D5-42CD-BD80-0BD8CE42F4FFQ34010407-FADC3E43-26CE-4560-A4C4-7683B191CE25Q34310509-2EFE252A-C692-418E-90FD-BFD42F9750A7Q34423464-9CDCA749-5AF7-468A-8687-199F6B906B30Q35207650-D3776212-5B84-449F-BB61-AF05F637B447Q36016677-ABB3DE76-497C-4C12-8BE4-B7BA35AD431BQ36060311-E7DC98FE-C1B0-47D8-A60C-383FA4088B42Q37170834-8D0A6C55-554B-4264-A80B-3CD927AC9BB0Q37478276-A9D55D12-2AC0-4A2A-8E95-AA70ED7404A8Q38575137-BB5B003A-AF56-477D-8E5D-BF1186460C02Q38762581-03EBF9BD-D851-4E14-93EA-2E01B4131C41Q40837834-8D88B01F-2226-40A6-AA8E-EE6DF0BF25E7Q47148197-FE0FE93F-EDB6-4234-8F06-1D9E99017D21Q53250468-AAC79756-19C1-436D-B2AE-DC6C33FECE90Q58693033-76B93AF5-1669-4836-9B08-5E738AD734D4Q58760622-5DFF467A-41A4-4ED5-889B-8ADA8E3E7619
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Granulysin-mediated tumor rejection in transgenic mice
@ast
Granulysin-mediated tumor rejection in transgenic mice
@en
Granulysin-mediated tumor rejection in transgenic mice
@nl
type
label
Granulysin-mediated tumor rejection in transgenic mice
@ast
Granulysin-mediated tumor rejection in transgenic mice
@en
Granulysin-mediated tumor rejection in transgenic mice
@nl
prefLabel
Granulysin-mediated tumor rejection in transgenic mice
@ast
Granulysin-mediated tumor rejection in transgenic mice
@en
Granulysin-mediated tumor rejection in transgenic mice
@nl
P2093
P2860
P1476
Granulysin-mediated tumor rejection in transgenic mice
@en
P2093
Alan M Krensky
Carol Clayberger
Lisa P Huang
Shu-Chen Lyu
P2860
P356
10.4049/JIMMUNOL.178.1.77
P407
P577
2007-01-01T00:00:00Z